Related references
Note: Only part of the references are listed.Comparative effect of statins on the risk of incident Alzheimer disease
Liliya Sinyavskaya et al.
NEUROLOGY (2018)
Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis
Kaarin J. Anstey et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease
Nophar Geifman et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease
Julie M. Zissimopoulos et al.
JAMA NEUROLOGY (2017)
Hypercholesterolaemia and vascular dementia
Jason P. Appleton et al.
CLINICAL SCIENCE (2017)
Statins for the prevention of dementia
Bernadette McGuinness et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Do Statins Impair Cognition? A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Brian R. Ott et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2015)
Statins and Cognitive Function: an Updated Review
Saurav Chatterjee et al.
CURRENT CARDIOLOGY REPORTS (2015)
Impact on Cognitive Function-Are All Statins the Same?
Nishant P. Shah et al.
CURRENT ATHEROSCLEROSIS REPORTS (2015)
HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study
V. Leduc et al.
MOLECULAR PSYCHIATRY (2015)
Comparison of the Risk of Psychological and Cognitive Disorders Between Persistent and Nonpersistent Statin Users
Steven M. Lilly et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Neil J. Stone et al.
CIRCULATION (2014)
Cholesterol in brain disease: sometimes determinant and frequently implicated
Mauricio G. Martin et al.
EMBO REPORTS (2014)
Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review
William J. Canestaro et al.
GENETICS IN MEDICINE (2014)
Statins and Neuroprotection: Basic Pharmacology Needed
W. Gibson Wood et al.
MOLECULAR NEUROBIOLOGY (2014)
Statins and Cognitive Function
Karl Richardson et al.
ANNALS OF INTERNAL MEDICINE (2013)
Statins and Cognition: A Systematic Review and Meta-analysis of Short- and Long-term Cognitive Effects
Kristopher J. Swiger et al.
MAYO CLINIC PROCEEDINGS (2013)
Statins in the prevention of dementia and Alzheimer's disease: A meta-analysis of observational studies and an assessment of confounding
William B. Wong et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
Drug transport across the blood-brain barrier
William M. Pardridge
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease
Dean G. Karalis
MAYO CLINIC PROCEEDINGS (2012)
Cholesterol: Its Regulation and Role in Central Nervous System Disorders
Matthias Orth et al.
CHOLESTEROL (2012)
Cholesterol Level and Statin Use in Alzheimer Disease II. Review of Human Trials and Recommendations
Nina E. Shepardson et al.
ARCHIVES OF NEUROLOGY (2011)
Comparison of Clinical Outcomes of Hydrophilic and Lipophilic Statins in Patients with Acute Myocardial Infarction
Min Chul Kim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2011)
Isoprenoids, small GTPases and Alzheimer's disease
Gero P. Hooff et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Statins and Cognitive Functioning in the Elderly: A Population-Based Study
Julian Benito-Leon et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Age-Varying Association Between Statin Use and Incident Alzheimer's Disease
Ge Li et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2010)
Characteristics of compounds that cross the blood-brain barrier
William A. Banks
BMC NEUROLOGY (2009)
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
Pierre Amarenco et al.
LANCET NEUROLOGY (2009)
Statin-Associated Adverse Cognitive Effects: Survey Results from 171 Patients
Marcella A. Evans et al.
PHARMACOTHERAPY (2009)
Statin Adverse Effects A Review of the Literature and Evidence for a Mitochondrial Mechanism
Beatrice A. Golomb et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2008)
Reduced risk of incident AD with elective statin use in a clinical trial cohort
D. Larry Sparks et al.
CURRENT ALZHEIMER RESEARCH (2008)
Statins reduce amyloid-β production through inhibition of protein Isoprenylation
Stephen M. Ostrowski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitors
Jeffrey A. Pfefferkorn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Estimated prevalence of people with cognitive impairment: Results from nationally representative community and institutional surveys
Amy B. Bernstein et al.
GERONTOLOGIST (2007)
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis - The ASTEROID trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Justification for the use of statins in primary prevention: An intervention trial evaluating rosuvastatin (JUPITER) - Can C-reactive protein be used to target statin therapy in primary prevention?
S Mora et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
M Schachter
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2005)
The UCSD statin study: a randomized controlled trial assessing the impact of statins on selected noncardiac outcomes
BA Golomb et al.
CONTROLLED CLINICAL TRIALS (2004)
Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults
MF Muldoon et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Statin-associated memory loss: Analysis of 60 case reports and review of the literature
LR Wagstaff et al.
PHARMACOTHERAPY (2003)
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis
MR Law et al.
BRITISH MEDICAL JOURNAL (2003)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J Shepherd et al.
LANCET (2002)
Testing cognitive function in elderly populations: the PROSPER study
PJ Houx et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease:: A 26-week randomized, placebo-controlled, double-blind trial
M Simons et al.
ANNALS OF NEUROLOGY (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people
K Rockwood et al.
ARCHIVES OF NEUROLOGY (2002)
A cholesterol-lowering drug reduces β-amyloid pathology in a transgenic mouse model of Alzheimer's disease
LM Refolo et al.
NEUROBIOLOGY OF DISEASE (2001)
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors
B Wolozin et al.
ARCHIVES OF NEUROLOGY (2000)
Effects of lovastatin on cognitive function and psychological well-being
MF Muldoon et al.
AMERICAN JOURNAL OF MEDICINE (2000)
Share Paper
